These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6494602)

  • 21. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee.
    Br J Dis Chest; 1988 Jul; 82(3):282-4. PubMed ID: 3073808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of tumor marker CA-125 serum levels for the follow-up of therapeutic responses in tuberculosis patients with and without serositis.
    Huang WC; Tseng CW; Chang KM; Hsu JY; Chen JH; Shen GH
    Jpn J Infect Dis; 2011; 64(5):367-72. PubMed ID: 21937816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
    Slutkin G; Schecter GF; Hopewell PC
    Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of rifampicin-isoniazid treatment in tuberculous meningitis].
    Hermida-Escobedo C; Peredo-Velarde MA
    Rev Latinoam Microbiol; 1985; 27(4):277-81. PubMed ID: 3837280
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
    Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
    Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field trial of short course chemotherapy for pulmonary tuberculosis: results at 30 months.
    Kecharananta P; Jittinandana A; Rattarasarn S; Sriyabhaya N
    J Med Assoc Thai; 1985 Jun; 68(6):283-7. PubMed ID: 4056632
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1992 Jun; 145(6):1429-32. PubMed ID: 1596014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tuberculous meningitis].
    Kaufman N; Raz R; Ben-Ami M; Flatau E
    Harefuah; 1989 Feb; 116(4):194-5. PubMed ID: 2731784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
    Zierski M; Bek E; Long MW; Snider DE
    Am Rev Respir Dis; 1980 Dec; 122(6):879-89. PubMed ID: 7006476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term intensive initial chemotherapy for pulmonary tuberculosis--preliminary report--can the duration of TB treatment be even shorter?
    Yang SP; Luh KT; Luan HW; Chang CE
    Kekkaku; 1978 Jan; 53(1):25-37. PubMed ID: 633698
    [No Abstract]   [Full Text] [Related]  

  • 38. Contralateral pleural effusion during chemotherapy for tuberculous pleural effusion.
    Puri MM; Arora VK
    Med J Malaysia; 2000 Sep; 55(3):382-4. PubMed ID: 11200723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection.
    Cook PP; Maldonado RA; Yarnell CT; Holbert D
    Clin Infect Dis; 2006 Aug; 43(3):271-5. PubMed ID: 16804838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
    Snider DE; Graczyk J; Bek E; Rogowski J
    Am Rev Respir Dis; 1984 Dec; 130(6):1091-4. PubMed ID: 6508006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.